POMC and primary adrenal insufficiency: Basal ACTH levels of 16 patients treated with mitotane were lower than the levels of 10 patients affected by primary adrenal insufficiency, and ACTH was also less responsive to corticotrophin-releasing hormone (CRH) stimulation in patients treated with mitotane [35].